Canada, United States Cervical Cancer Screening Market: 4,000 Women in the United States Have Died from Cervical Cancer in 2016 – Research and Markets

Sigue a La Opinión en Facebook

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Canada,
United States Cervical Cancer Screening Market & Patients, By Test Type
(Pap Smear HPV DNA VIA) in North America”
report to their
offering.

Canada, United States Cervical Cancer Screening Market & Patients, By
Test Type (Pap Smear HPV DNA VIA) in North America report provides a
comprehensive analysis and forecast till 2020. This report provides a
complete analysis of 2 Countries Cervical Cancer Test Market & Number of
Cervical Cancer Population.

Cervical cancer is one of the most common causes of cancer death for
North American women. It is estimated that over 4,000 women in the
United States and 400 women in Canada die from cervical cancer in 2016.
However, it is also one of the most preventable types of cancer.

Pap smear and HPV DNA test are two most popular testing methods to
diagnose cervical cancer cases in North America. United States is the
leader in North America cervical cancer test market. It holds over 90
percent testing population share alone, and is likely to maintain its
position in forecasting period as well due to women getting regular Pap
tests.

Key Topics Covered:

1. Executive Summary

2. North America Cervical Cancer Test (Screening) Population & Forecast

3. North America Cervical Cancer Test (Screening) Market & Forecast

4. North America Cervical Cancer Test (Screening) Population Share,
Market Share & Forecast

5. United States – Cervical Cancer Test Analysis

6. Canada – Cervical Cancer Test Analysis

7. Cervical Cancer Test Market Growth Drivers

8. Challenges in Cervical Cancer Test Market

For more information about this report visit http://www.researchandmarkets.com/research/rwnf5s/canada_united

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Diagnostics,
In
Vitro Diagnostics
, Infectious
Disease Testing